MedPath

Methylergonovine Maleate

Methylergonovine Maleate Tablets USP A211455

Approved
Approval ID

2fbdc9c4-b9d4-4796-adda-6144bdea0990

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 31, 2020

Manufacturers
FDA

ATLANTIC BIOLOGICALS CORP.

DUNS: 047437707

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Methylergonovine Maleate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code17856-3655
Application NumberANDA211455
Product Classification
M
Marketing Category
C73584
G
Generic Name
Methylergonovine Maleate
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 31, 2020
FDA Product Classification

INGREDIENTS (11)

METHYLERGONOVINE MALEATEActive
Quantity: 0.2 mg in 1 1
Code: IR84JPZ1RK
Classification: ACTIB
ACACIAInactive
Code: 5C5403N26O
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
TARTARIC ACIDInactive
Code: W4888I119H
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Methylergonovine Maleate - FDA Drug Approval Details